JP2021073257A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021073257A5 JP2021073257A5 JP2021012097A JP2021012097A JP2021073257A5 JP 2021073257 A5 JP2021073257 A5 JP 2021073257A5 JP 2021012097 A JP2021012097 A JP 2021012097A JP 2021012097 A JP2021012097 A JP 2021012097A JP 2021073257 A5 JP2021073257 A5 JP 2021073257A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- pharmaceutically acceptable
- hydrate
- inflammatory pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 3
- 206010065390 Inflammatory pain Diseases 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical group CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1507048.5 | 2015-04-24 | ||
| GBGB1507048.5A GB201507048D0 (en) | 2015-04-24 | 2015-04-24 | Treatment of pain |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555657A Division JP2018520984A (ja) | 2015-04-24 | 2016-04-22 | 疼痛の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021073257A JP2021073257A (ja) | 2021-05-13 |
| JP2021073257A5 true JP2021073257A5 (enExample) | 2021-08-12 |
Family
ID=53488643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555657A Pending JP2018520984A (ja) | 2015-04-24 | 2016-04-22 | 疼痛の治療 |
| JP2021012097A Withdrawn JP2021073257A (ja) | 2015-04-24 | 2021-01-28 | 疼痛の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555657A Pending JP2018520984A (ja) | 2015-04-24 | 2016-04-22 | 疼痛の治療 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20180104223A1 (enExample) |
| EP (1) | EP3285767B8 (enExample) |
| JP (2) | JP2018520984A (enExample) |
| KR (1) | KR20170139047A (enExample) |
| CN (1) | CN107530330A (enExample) |
| AU (1) | AU2016252237B2 (enExample) |
| BR (1) | BR112017019337A2 (enExample) |
| CA (1) | CA2979160A1 (enExample) |
| DK (1) | DK3285767T3 (enExample) |
| EA (1) | EA032512B1 (enExample) |
| ES (1) | ES2720035T3 (enExample) |
| GB (1) | GB201507048D0 (enExample) |
| HK (1) | HK1249865B (enExample) |
| HU (1) | HUE043871T2 (enExample) |
| IL (1) | IL254155B (enExample) |
| MX (1) | MX2017013047A (enExample) |
| PL (1) | PL3285767T3 (enExample) |
| PT (1) | PT3285767T (enExample) |
| SG (1) | SG11201707870SA (enExample) |
| TR (1) | TR201905392T4 (enExample) |
| WO (1) | WO2016170353A1 (enExample) |
| ZA (1) | ZA201705847B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201304526D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| AU2016366635A1 (en) * | 2015-12-07 | 2018-06-21 | Benevolentai Cambridge Limited | VAP-1 inhibitors for treating pain |
| GB201618029D0 (en) * | 2016-10-25 | 2016-12-07 | Proximagen Ltd | New process |
| GB201709136D0 (en) * | 2017-06-08 | 2017-07-26 | Proximagen Ltd | New therapeutic uses of enzyme inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4055593A (en) * | 1992-05-15 | 1993-12-13 | University Of Saskatchewan | Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
| WO2006028269A2 (en) * | 2004-09-09 | 2006-03-16 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 ihibitory activity |
| US20070066646A1 (en) * | 2005-08-02 | 2007-03-22 | Genmedica Therapeutics Sl | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof |
| EP2029164B1 (en) | 2006-06-07 | 2015-12-23 | The Board of Trustees of the Leland Stanford Junior University | Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| US8263616B2 (en) * | 2008-09-16 | 2012-09-11 | Proximagen Ltd | 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds |
| FI20115234A0 (fi) * | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| CA2915163A1 (en) * | 2013-06-12 | 2014-12-18 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| HUE042625T2 (hu) * | 2014-04-15 | 2019-07-29 | Pecsi Tudomanyegyetem | Szemikarbazid-szenzitiv amin-oxidáz gátlók fájdalomcsillapítóként való alkalmazásra traumás neuropátiában és neurogén gyulladásban |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
-
2015
- 2015-04-24 GB GBGB1507048.5A patent/GB201507048D0/en not_active Ceased
-
2016
- 2016-04-22 TR TR2019/05392T patent/TR201905392T4/tr unknown
- 2016-04-22 EA EA201792123A patent/EA032512B1/ru not_active IP Right Cessation
- 2016-04-22 US US15/567,555 patent/US20180104223A1/en not_active Abandoned
- 2016-04-22 WO PCT/GB2016/051122 patent/WO2016170353A1/en not_active Ceased
- 2016-04-22 CA CA2979160A patent/CA2979160A1/en active Pending
- 2016-04-22 EP EP16718885.3A patent/EP3285767B8/en active Active
- 2016-04-22 SG SG11201707870SA patent/SG11201707870SA/en unknown
- 2016-04-22 KR KR1020177032024A patent/KR20170139047A/ko not_active Withdrawn
- 2016-04-22 MX MX2017013047A patent/MX2017013047A/es unknown
- 2016-04-22 PL PL16718885T patent/PL3285767T3/pl unknown
- 2016-04-22 HK HK18109397.0A patent/HK1249865B/en not_active IP Right Cessation
- 2016-04-22 JP JP2017555657A patent/JP2018520984A/ja active Pending
- 2016-04-22 PT PT16718885T patent/PT3285767T/pt unknown
- 2016-04-22 CN CN201680023299.XA patent/CN107530330A/zh active Pending
- 2016-04-22 AU AU2016252237A patent/AU2016252237B2/en not_active Ceased
- 2016-04-22 ES ES16718885T patent/ES2720035T3/es active Active
- 2016-04-22 DK DK16718885.3T patent/DK3285767T3/en active
- 2016-04-22 HU HUE16718885A patent/HUE043871T2/hu unknown
- 2016-04-22 BR BR112017019337-0A patent/BR112017019337A2/pt not_active Application Discontinuation
-
2017
- 2017-08-24 IL IL254155A patent/IL254155B/en active IP Right Grant
- 2017-08-28 ZA ZA2017/05847A patent/ZA201705847B/en unknown
-
2021
- 2021-01-28 JP JP2021012097A patent/JP2021073257A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021073257A5 (enExample) | ||
| JP2022058688A5 (enExample) | ||
| HRP20250148T1 (hr) | Specifični triptamini za uporabu u liječenju poremećaja raspoloženja | |
| JP2011522816A5 (enExample) | ||
| JP2013507415A5 (enExample) | ||
| JP2018168191A5 (enExample) | ||
| JP2020512337A5 (enExample) | ||
| JP2021152008A5 (enExample) | ||
| JP2017222722A5 (enExample) | ||
| JP2005526107A5 (enExample) | ||
| JP2005500357A5 (enExample) | ||
| JP2014526503A5 (enExample) | ||
| JP2022163049A5 (enExample) | ||
| JP2020521797A5 (enExample) | ||
| JP2018090566A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| JP2009517411A5 (enExample) | ||
| JP2011518176A5 (enExample) | ||
| JP2020529995A5 (enExample) | ||
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| JP2010500284A5 (enExample) | ||
| JP2002534477A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP2008533079A5 (enExample) |